Yvonne Yamanaka, Ph.D., is a Principal at venBio with a background in biological engineering and life science company creation. Prior to joining venBio, Yvonne was a member of the venture creation team at Flagship Pioneering, where she invented technologies and helped launch life science companies. Yvonne began her research career at EMD/Merck Serono leading the development of an immunotherapy technology that she and teammates had designed as graduate students.
Yvonne received her Ph.D. in Biological Engineering from MIT, where she was a Siebel Scholar, NSF Graduate Research Fellow, and a winner of the Merck Serono Innovation Cup. She received her B.S.E. in Biomedical Engineering from Duke University, where she was an Angier B. Duke and Goldwater Scholar.